Histological detection of catalytic ferrous iron with the selective turn-on fluorescent probe RhoNox-1 in a Fenton reaction-based rat renal carcinogenesis model

References

• Wriggleworth JM, Baum H. The biochemical function of iron. In: Jacobs A, Worwood M (eds.). Iron in biochemistry and medicine, II. London: Academic Press; 1980. pp. 29–86.
   Google Scholar
• Weinberg ED. The hazards of iron loading. Metallomics 2010;2:732–740.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. Iron as a target of chemoprevention for longevity in humans. Free Radic Res 2011;45:906–917.
   PubMed Web of Science ®Google Scholar
• Weinberg ED. Iron availability and infection. Biochim Biophys Acta 2009;1790:600–605.
   PubMed Web of Science ®Google Scholar
• Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell 2010;142:24–38.
   PubMed Web of Science ®Google Scholar
• Weinberg ED. The role of iron in cancer. Eur J Cancer Prev 1996;5:19–36.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996;20:553–566.
   PubMed Web of Science ®Google Scholar
• Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 2009;100:9–16.
   PubMed Web of Science ®Google Scholar
• Yuan XM. Apoptotic macrophage-derived foam cells of human atheromas are rich in iron and ferritin, suggesting iron-catalysed reactions to be involved in apoptosis. Free Radic Res 1999;30:221–231.
   PubMed Web of Science ®Google Scholar
• Rowley D, Gutteridge JM, Blake D, Farr M, Halliwell B. Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci (Lond) 1984;66:691–695.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. New York: Oxford University Press; 2007.
   Google Scholar
• Fenton HJH. Oxidation of tartaric acid in presence of iron. J Chem Soc 1894;65:899–910.
   Google Scholar
• Hirayama T, Okuda K, Nagasawa H. A highly selective turn-on fluorescent probe fro iron(II) to visualize labile iron in living cells. Chem Sci 2013;4:1250–1256.
   Web of Science ®Google Scholar
• Ebina Y, Okada S, Hamazaki S, Ogino F, Li JL, Midorikawa O. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats. J Natl Cancer Inst 1986;76:107–113.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994;91:2616–2620.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Mori T, Dizdaroglu M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. Int J Cancer 1994;57:123–128.
   PubMed Web of Science ®Google Scholar
• Nishiyama Y, Suwa H, Okamoto K, Fukumoto M, Hiai H, Toyokuni S. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate. Jpn J Cancer Res 1995; 86:1150–1158.
   PubMedGoogle Scholar
• Toyokuni S, Luo XP, Tanaka T, Uchida K, Hiai H, Lehotay DC. Induction of a wide range of C2–12 aldehydes and C7–12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 1997;22:1019–1027.
   PubMed Web of Science ®Google Scholar
• Akatsuka S, Yamashita Y, Ohara H, Liu YT, Izumiya M, Abe K, et al. Fenton reaction induced cancer in wild type rats recapitulates genomic alterations observed in human cancer. PLoS ONE 2012;7:e43403.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Nishiyama Y, Okada K, Hirota K, Matsui M, Yodoi J, et al. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. Lab Invest 1997;77:145–155.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Sagripanti JL. Iron-mediated DNA damage: sensitive detection of DNA strand breakage catalyzed by iron. J Inorg Biochem 1992;47:241–248.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Sagripanti J-L. DNA single- and double-strand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis 1993;14:223–227.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Sagripanti JL. Iron chelators modulate the production of DNA strand breaks and 8- hydroxy-2’-deoxyguanosine. Free Radic Res 1999;31:123–128.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Okada S, Hamazaki S, Minamiyama Y, Yamada Y, Liang P, et al. Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice. Cancer Res 1990;50:5574–5580.
   PubMed Web of Science ®Google Scholar
• Okada S, Minamiyama Y, Hamazaki S, Toyokuni S, Sotomatsu A. Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse proximal renal tubules. Arch Biochem Biophys 1993;301:138–142.
   PubMed Web of Science ®Google Scholar
• Kawai Y, Furuhata A, Toyokuni S, Aratani Y, Uchida K. Formation of acrolein-derived 2’-deoxyadenosine adduct in an iron-induced carcinogenesis model. J Biol Chem 2003; 278:50346–50354.
   PubMed Web of Science ®Google Scholar
• Veuthey T, Hoffman D, Vaidya VS, Wessling-Resnick M. Impaired renal function and development in Belgrade rats. Am J Physiol Renal Physiol 2014;306:F333–343.
   Web of Science ®Google Scholar
• Kasai H. Analysis of a form of oxidative DNA damage, 8- hydroxy-2’-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997;387:147–163.
   PubMed Web of Science ®Google Scholar
• Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003;42:318–343.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Tanaka T, Hattori Y, Nishiyama Y, Ochi H, Hiai H, et al. Quantitative immunohistochemical determination of 8-hydroxy-2’-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997;76:365–374.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Miyake N, Hiai H, Hagiwara M, Kawakishi S, Osawa T, Uchida K. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 1995; 359:189–191.
   PubMed Web of Science ®Google Scholar